M. Toft-Nielsen
Hvidovre Hospital(DK)Copenhagen University Hospital(DK)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Regulation of Appetite and Obesity, Pancreatic function and diabetes
Most-Cited Works
- → Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients(2001)837 cited
- → Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects(1995)716 cited
- → Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.(1999)334 cited
- → Determinants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes(2001)160 cited
- → Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia(1998)133 cited
- → Additive Glucose-Lowering Effects of Glucagon-Like Peptide-1 and Metformin in Type 2 Diabetes(2001)62 cited
- → Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.(2000)37 cited
- → Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass(2017)12 cited
- → No Effect of Beta-adrenergic Blockade on Hypoglycaemic Effect of Glucagon-like Peptide-1 (GLP-1) in Normal Subjects(1996)8 cited